These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28981740)

  • 21. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
    Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
    J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery.
    Park H; Jeong CW; Yuk H; Ku JH; Kim HH; Kwak C; Kim I
    Clin Appl Thromb Hemost; 2019; 25():1076029618823288. PubMed ID: 30808214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of venous thromboembolism in women with uterine carcinosarcoma.
    Matsuo K; Ross MS; Im DD; Klobocista MM; Bush SH; Johnson MS; Takano T; Blake EA; Ikeda Y; Nishimura M; Ueda Y; Shida M; Hasegawa K; Baba T; Adachi S; Yokoyama T; Satoh S; Machida H; Yanai S; Iwasaki K; Miyake TM; Takeuchi S; Takekuma M; Nagano T; Yunokawa M; Pejovic T; Omatsu K; Shahzad MMK; Kelley JL; Ueland FR; Roman LD
    Gynecol Oncol; 2018 Feb; 148(2):267-274. PubMed ID: 29248197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective Analysis of Risk Factors for Venous Thromboembolism in 283 Patients with Lung Cancer during Systemic Therapy].
    Liu Y; Gu Y; Yi F; Cao B
    Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):419-426. PubMed ID: 31315780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
    Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
    BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol.
    Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM
    Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
    Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.
    Shah MA; Capanu M; Soff G; Asmis T; Kelsen DP
    J Thromb Haemost; 2010 Aug; 8(8):1702-9. PubMed ID: 20553384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil-Lymphocyte Ratio is a Predictor of Venous Thromboembolism in Gastric Cancer Patients.
    Du P
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study.
    Park K; Ryoo BY; Ryu MH; Park SR; Kang MJ; Kim JH; Han S; Kang YK
    World J Gastrointest Oncol; 2017 Apr; 9(4):176-183. PubMed ID: 28451065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
    Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
    Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
    Pant A; Liu D; Schink J; Lurain J
    Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
    Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
    Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
    Brand JS; Hedayati E; Bhoo-Pathy N; Bergh J; Hall P; Humphreys K; Ludvigsson JF; Czene K
    Cancer; 2017 Feb; 123(3):468-475. PubMed ID: 27727456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.